Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FE.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HA.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HA.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HA.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GM.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GM.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GM.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GM.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GM.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GM.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.3.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCCEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCCEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCCECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCCECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCCEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCCEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCCENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCCENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used